From Europe. For the global patent community.
Trending Topics:
JUVE Patent Supplementary protection certificates

Supplementary protection certificates

Cases
The Netherlands

Dutch Patent Office and District Court deny SPC for Novartis/Genmab MS drug

The District Court of The Hague has backed the Netherlands Patent Office's rejection of a request by Novartis and Genmab to grant a supplementary prot ...

2 October 2023 by Amy Sandys
Cases
Teva, Bristol-Myers Squibb
France

BMS and Gide x Regimbeau repel Teva invalidity case against apixaban patent

The Judicial Court of Paris has rejected Teva's pleas for an invalidation of a patent belonging to Bristol-Myers Squibb, which covers active ingredien ...

20 June 2023 by Amy Sandys
Cases
Pharmaceuticals

Court of Appeal confirms invalidity of Bristol-Myers Squibb apixaban patent

In London, the Court of Appeal has rejected an appeal by Bristol-Myers Squibb regarding the invalidation of a patent covering blood-clot prevention dr ...

9 May 2023 by Amy Sandys
Cases
MSD, CJEU. Inegy
Pharmaceuticals

MSD and generics await CJEU ruling in French SPC battle over Inegy

In France, competing parties must wait for a final CJEU decision in the dispute over a supplementary protection certificate for MSD's cholesterol-lowe ...

15 February 2023 by Konstanze Richter
Cases
Supplementary Protection Certificates

Paris Court of Appeal reverses case law in Dana Farber vs. INPI

In a recent ruling, the Paris Court of Appeal has reversed the previous case law in France on supplementary protection certificates. The court overtur ...

10 June 2022 by Konstanze Richter
Cases
Sandoz, Teva
Pharmaceuticals

Sandoz and Teva invalidate blockbuster apixaban patent and SPC

The UK High Court has invalidated a Bristol-Myers Squibb patent, which covers a blockbuster drug and SPC for the treatment and prevention of blood clo ...

8 April 2022 by Amy Sandys
Cases
Combination drug SPCs

CJEU to hear SPC referrals in MSD Inegy and Janumet cases

Courts in Ireland and Finland have referred questions concerning Articles 3a and 3c of the current SPC Regulation to the CJEU, to clarify the granting ...

30 March 2022 by Amy Sandys
Cases
Menzis, AstraZeneca
The Netherlands

AstraZeneca and Hoyng avert damages payment to health insurer Menzis

Dutch health insurer Menzis will not receive compensation for unlawful enforcement of a preliminary injunction by pharma giant AstraZeneca. Instead, t ...

18 January 2022 by Amy Sandys
People & Business
Machteld Hiemstra, Pinsent Masons
The Netherlands

Pinsent Masons grows new Amsterdam office with life sciences partner

The new Amsterdam office of Pinsent Masons has welcomed Machteld Hiemstra, who joins from Simmons & Simmons, as its third partner. Hiemstra brings ...

7 June 2021 by Amy Sandys
Cases
Second medical use

Alcon wins with Bristows over glaucoma drug patent validity

The UK High Court has upheld in revocation proceedings a patent owned by Alcon, which covers a drug used to treat the eye condition glaucoma. The deci ...

20 May 2021 by Amy Sandys
Cases
Judicial Court of Paris, MSD
Cholesterol-lowering drug

Judicial Court of Paris halts SPC battle between MSD and generics

A Paris court has issued four decisions, pausing a long-running cholesterol drug battle between MSD and generics in France. Proceedings on the merits ...

30 April 2021 by Konstanze Richter
Cases
CJEU case law, Court of Appeal
Supplementary protection certificates

Paris Court of Appeal applies CJEU case law in three SPC judgments

The Paris Court of Appeal has applied CJEU case law in three separate landmark rulings on SPC applications in France. The case law is based on the 202 ...

25 February 2021 by Konstanze Richter
Cases
Daiichi Sankyo
Pharmaceutical licences

Data exclusivity means market exclusivity for Daiichi Sankyo

Data exclusivity could be the emerging battle arena for German IP lawyers in the fight over generic licences. Until now, this property right has been ...

18 November 2020 by Christina Schulze
Cases
Truvada
Supplementary protection certificates

Federal Court of Justice destroys SPC for Gilead blockbuster drug Truvada

Gilead has now also failed to protect its HIV blockbuster drug Truvada in Germany, in the Europe-wide dispute over its property rights. The German Fed ...

23 September 2020 by Konstanze Richter
Legal Commentary
SPC regulations
Supplementary protection certificates

UK government responds to views on draft SPC legislation

The UK government has published its response on proposed changes to SPC legislation following consultation. Brexit will have an impact on SPCs in the ...

20 July 2020 by Amy Sandys
Popular